This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hoelzer D, Thiel E, Loffler B, Buchner T, Ganser A, Heil G et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123–131.
Durrant IJ, Prentice HG, Richards SM . Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research council randomized trial UKALL XA. Br J Haematol 1997; 99: 84–92.
Annino L, Vegna ML, Camera A, Specchia G, Visan G, Fioritoni G et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863–871.
Faderl S, Jeha S, Kantarjian HM . The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98: 1337–1354.
Chandy M . Childhood acute lymphoblastic leukemia in India: an approach to management in a three-tier society. Med Pediatr Oncol 1995; 25: 197–203.
Raje N, Pai S, Vaidya S, Gopal R, Parikh P, Saikia T et al. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India. Leuk Lymphoma 1994; 14: 285–290.
Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94: 1209–1217.
Gökbuget N, Hoelzer D, Arnold R, Bohme A, Bartram CR, Freund M et al. Treatment of adult ALL according to the protocols of the German Multicenter Study Group for Adult ALL (GMALL). Hematol Oncol Clin North Am 2000; 14: 1307–1325.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bajel, A., George, B., Mathews, V. et al. Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol. Leukemia 21, 2230–2233 (2007). https://doi.org/10.1038/sj.leu.2404785
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404785
This article is cited by
-
Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, l-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL
Annals of Hematology (2016)
-
Cervical Lymphoma Mimicking Cervical Fibroid: A Report of Three Cases and Review of Literature
Indian Journal of Gynecologic Oncology (2015)
-
Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine
Medical Oncology (2010)